DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global point-of-care diagnostics market grew at a CAGR of 9.5% during 2014-2019. Looking forward, the publisher expects the market to continue its strong growth during the next five years.
Point-of-care (PoC) diagnostics refer to the medical testing conducted to enable rapid analysis and obtain immediate results. PoC testing involves various portable instruments for glucose monitoring and infectious disease, cardiometabolic and urinalysis testing, among others. It aids in the early detection of critical illnesses, thus providing an enhanced patient-centric approach of healthcare. This kind of medical testing is widely utilized for supplying diagnostic facilities to remote locations where it is difficult to set up clinical laboratories. Owing to this, PoC testing essentials are integrated with medical vehicles, including helicopters, air ambulances, airplanes and spacecraft.
The growing prevalence of chronic diseases, which lead to increased morbidity and mortality rates, is one of the key factors driving the growth of the market. Furthermore, the increasing geriatric population across the globe, which is more prone to chronic illnesses, is also providing a thrust to the market. Moreover, infectious diseases such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), dengue fever, malaria and influenza require timely diagnosis and rapid screening, which is usually done through PoC diagnostic devices.
Additionally, owing to the development of miniaturized devices and the integration with wireless technology, healthcare professionals can maintain electronic medical records (EMR) and provide more personalized intervention to individual patients. These records enable the direct transmission of test results from PoC devices to a specialist in the lab, thus minimizing the chances of discrepancies in the obtained test results. Moreover, the advent of home-testing cancer kits, which can actively monitor and analyze tumor cells, is further acting as a growth-inducing factor. Other factors, including enhanced research and development (R&D) to develop molecular diagnostic devices and the rising awareness for early detection of diseases, are projected to drive the market growth.
Companies Mentioned
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton
- Dickinson and Company
- F. Hoffmann-La Roche AG
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- Pts Diagnostics
- Qiagen
- Siemens
-
Trinity Biotech
Key Questions Answered in this Report:
- How has the global point-of-care diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the platform?
- What is the breakup of the market based on the prescription mode?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global point-of-care diagnostics market and who are the key players?
-
What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Point-of-Care Diagnostic Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast
6 Market Breakup by Product Type
6.1 Glucose Monitoring Kit
6.2 Cardio-Metabolic Monitoring Kit
6.3 Pregnancy and Fertility Testing Kit
6.4 Infectious Disease Testing Kit
6.5 Cholesterol Test Strip
6.6 Hematology Testing Kit
6.7 Others
7 Market Breakup by Platform
7.1 Lateral Flow Assays
7.2 Dipsticks
7.3 Microfluidics
7.4 Molecular Diagnostics
7.5 Immunoassays
8 Market Breakup by Prescription Mode
8.1 Prescription-Based Testing
8.2 OTC Testing
9 Market Breakup by End-User
9.1 Professional Diagnostic Centers
9.2 Home Care
9.3 Research Laboratories
9.4 Others
10 Market Breakup by Region
10.1 North America
10.2 Asia Pacific
10.3 Europe
10.4 Latin America
10.5 Middle East and Africa
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/5vnmi4
